Editorial: Model-informed drug development and precision dosing in clinical pharmacology practice

Ke Hu; Meng Fu; Xueting Huang; Sumei He; Zheng Jiao; Dongdong Wang

doi:10.3389/fphar.2023.1224980

Editorial: Model-informed drug development and precision dosing in clinical pharmacology practice

Front Pharmacol. 2023 Jun 30:14:1224980. doi: 10.3389/fphar.2023.1224980. eCollection 2023.

Authors

Ke Hu¹, Meng Fu², Xueting Huang¹, Sumei He³, Zheng Jiao⁴, Dongdong Wang¹

Affiliations

¹ Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy and School of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, China.
² Department of Clinical Pharmacology, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
³ Department of Pharmacy, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, Jiangsu, China.
⁴ Department of Pharmacy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

No abstract available

Keywords: clinical pharmacology; model-informed drug development; model-informed precision dosing; modeling and simulation; practice.

Publication types

Editorial

Grants and funding

This work was supported by the National Natural Science Foundation of China (No. 82104296), Xuzhou Special Fund for Promoting Scientific and Technological Innovation (No. KC21257), Initializing Fund of Xuzhou Medical University (No. RC20552111), Fusion Innovation Project of Xuzhou Medical University (No. XYRHCX2021011), Jiangsu Province Education Science Planning Project (No. C/2022/01/36), and Xuzhou Medical University Labor Education Special Support Project (No. X1d202209).